Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metagenomi (MGX) Long-Term Investments (2023 - 2025)

Metagenomi (MGX) has disclosed Long-Term Investments for 3 consecutive years, with $2.2 million as the latest value for Q4 2025.

  • Quarterly Long-Term Investments fell 37.51% to $2.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.2 million through Dec 2025, down 37.51% year-over-year, with the annual reading at $2.2 million for FY2025, 37.51% down from the prior year.
  • Long-Term Investments for Q4 2025 was $2.2 million at Metagenomi, roughly flat from $2.2 million in the prior quarter.
  • The five-year high for Long-Term Investments was $10.6 million in Q3 2024, with the low at $1.3 million in Q1 2025.
  • Average Long-Term Investments over 3 years is $5.9 million, with a median of $7.1 million recorded in 2023.
  • The sharpest move saw Long-Term Investments skyrocketed 50.79% in 2024, then crashed 84.84% in 2025.
  • Over 3 years, Long-Term Investments stood at $8.5 million in 2023, then plummeted by 59.55% to $3.4 million in 2024, then plummeted by 37.51% to $2.2 million in 2025.
  • According to Business Quant data, Long-Term Investments over the past three periods came in at $2.2 million, $2.2 million, and $1.3 million for Q4 2025, Q3 2025, and Q1 2025 respectively.